2-6 June 2018 Toronto
P-014 | HOW ETHNIC DONOR INFORMATION SUPPORTS REQUESTS FOR TRANSFUSION | Benjamin Villaseran | Received |
P-019 | IMPROVEMENTS IN PERIOPERATIVE BLOOD MANAGEMENT FOR PATIENTS ELIGIBLE FOR ELECTRONIC CROSSMATCH | Kerry OBrien | Received |
P-033 | INTERNATIONALLY STANDARDIZED CODING AND LABELING IN BLOOD TRANSFUSION 24 YEARS LATER | Mónica Freire | Received |
P-039 | NHSBT SUPPLY OF RARE RED CELLS 2015-2017 | REKHA ANAND | Received |
P-047 | USAGE OF O RHD NEGATIVE RED CELLS IN FINLAND | Tiia Kivipuro | Received |
P-051 | IMPACT OF 7-DAY PLATELETS ON INVENTORY MANAGEMENT AT A PEDIATRIC INSTITUTION | Alex Ryder | Received |
P-053 | CHALLENGES TO PROVIDING BLOOD TO ALLOIMMUNIZED AFRICAN AMERICAN PATIENTS | Margaret Keller | Received |
P-057 | INNOVATION OF BLOOD TRANSPORTATION SYSTEM IN LUMAJANG BLOOD CENTER | Halimi Maksum | Received |
P-059 | PATIENT BLOOD MANAGEMENT: ANALYZING THE UTILITY OF UTILIZATION METRICS | James Kelley | Received |
P-062 | GRANULOCYTES APHERESIS TRANSFUSIONS: THE FRENCH BLOOD MANAGEMENT IN 2016-2017 | Geneviève WOIMANT | Received |
P-081 | PROCESS IMPROVEMENT TO DECREASE BLOOD PRODUCT WASTAGE AND IMPROVE COLD CHAIN EFFICACY | Ritchelle Tabao | Received |
P-087 | THE IMPACT OF ANALYTICAL VARIATION OF HEMOGLOBIN MEASUREMENT ON BLOOD DONORS HEMOGLOBIN AND DEFERRAL RATE | Johanna CASTRÉN | Received |
P-094 | TYPING NON-CONFORMING SAMPLES DUE TO MISLABELING ERRORS FOR IMPROVED DETECTION OF WRONG BLOOD IN TUBE (WBIT) | Ann Wilson | Received |
P-095 | FEEDBACK OF AN EXTERNAL PROFICIENCY TESTING SCHEME BY INTERLABORATORY COMPARISON FOR QUALITY CONTROL OF BLOOD PRODUCTS AT THE EFS | Stéphane Bégué | Received |
P-109 | PREDICTING BLOOD DONATION INTENTION: THE IMPORTANCE OF FEAR | Philippe Gilchrist | Received |
P-114 | PREVALENCE OF CARDIO-VASCULAR RISK FACTORS AMONG BLOOD DONORS IN FRANCE | Anne-Marie Fillet | Received |
P-119 | AUSTRALIAN BLOOD DONORS AND NON-DONORS VIEWS ON NON-CASH INCENTIVES FOR BLOOD DONATION | Nina Van Dyke | Received |
P-134 | PROBABILITY TO BE A BLOOD DONOR IN OSLO DEPENDING ON GEOGRAPHICAL FACTORS | Lise Sofie H Nissen-Meyer | Received |
P-135 | YOUTHTUBE A CASE STUDY ON A BLOOD DONATION SHORT FILM COMPETITION A 2-YEAR REVIEW | Irene van Schalkwyk | Received |
P-138 | VOLUNTARY NON-REMUNERATED BLOOD DONATION IN THE RUSSIAN FEDERATION | Alexander Chechetkin | Received |
P-154 | FROM FIRST-TIME PLASMA DONOR TO ESTABLISHING A ROUTINE: HOW DO DONORS DECIDE HOW OFTEN THEY WOULD LIKE TO DONATE PLASMA? | Nina Van Dyke | Received |
P-196 | CALCIUM IN DRINKING WATER EFFECT ON IRON STORES IN DANISH BLOOD DONORS: RESULTS FROM THE DANISH BLOOD DONOR STUDY (DBDS) | Andreas Stribolt Rigas | Received |
P-200 | HAEMOGLOBIN REGENERATION IN A FRENCH POPULATION OF NEW DONORS | Jean-Yves Py | Received |
P-201 | FRENCH ORGANISATION TO PREVENT DONATIONS FROM ANAEMIC DONORS IS QUITE EFFECTIVE | Jean-Yves Py | Received |
P-205 | STANDING ENHANCES VASOVAGAL SYMPTOMS ELICITED BY STIMULI ASSOCIATED WITH BLOOD BUT NOT OTHER EMOTIONAL STRESSORS | Philippe Gilchrist | Received |
P-206 | DOES ANTI-HYPERTENSIVE MEDICATION POSE A RISK FOR THE DONOR? | Kathrine M Neuman Johnsen | Received |
P-228 | WHOLE BLOOD PROCESSING USING DINCH BASED BLOOD CONTAINERS | Konstanze Aurich | Received |
P-233 | A FIRST AUSTRALIAN STUDY WITH A NATIONAL APPROACH TO SYSTEMATIC TESTING OF DONORS WHEN THEIR WHOLE BLOOD DONATIONS ARE REPEATEDLY DISCARDED DUE TO RED CELL PROCESSING ISSUES | Phillip Mondy | Received |
P-236 | STUDY OF MAGNESIUM ADDITIVE EFFECT ON RBC UNITS IN COMPARISON WITH UNITS ENRICHED WITH GLUATHIONE | Sima Zolfaghari | Received |
P-244 | EFFECT OF PRE-PROCESSING HOLDING TIME ON THE QUALITY OF PLASMA RECOVERED FROM LEUKOREDUCED WHOLE BLOOD DONATIONS | William Sheffield | Received |
P-246 | RED BLOOD CELLS FOR INTRAUTERINE TRANSFUSION: MEETING THE NEED THROUGH PHENOTYPING AND ANTI-CMV ANTIBODY TESTING | Robert Romans | Received |
P-265 | 2, 3 DIPHOSPHOGLYCERATE CONTENT AND OXYGEN AFFINITY OF HEMANEXT RED BLOOD CELLS STORED UNDER OXYGEN REDUCED CONDITIONS | Samuel Sowemimo-Coker | Received |
P-271 | TRANSFUSION OF FRESH AND DATE OF EXPIRY RED BLOOD CELLS IN A SHEEP MODEL - AGE DOES NOT MATTER | Gabriela Simonova | Received |
P-275 | OXYGEN IN RED BLOOD CELL CONCENTRATES: INFLUENCE OF DONORS CHARACTERISTICS, LOCATION AND BLOOD PROCESSING | Michel Prudent | Received |
P-277 | PROTHROMBIN KNOCKDOWN ABROGATES ANTI-HEMORRHAGIC PROPERTIES OF TRANSFUSABLE PLASMA IN A MOUSE MODEL OF COAGULOPATHY | William Sheffield | Received |
P-290 | EXPERIENCE OF THE IMPLEMENTATION OF INTERCEPT AMOTOSALEN TREATMENT FOR PLATELETS | Thibaut BOCQUET | Received |
P-298 | SWIRLING SCORE LOSS IN APHERESIS PLATELETS FOLLOWING THE IMPLEMENTATION OF INTERCEPT PATHOGEN INACTIVATION | Thibaut BOCQUET | Received |
P-320 | RETENTION OF THROMBIN GENERATION ACTIVITY IN POOLED WHOLE BLOOD-DERIVED PLASMA AFTER AMOTOSALEN-UVA PATHOGEN INACTIVATION AND STORAGE IS INDEPENDENT OF ABO BLOOD GROUPS | catherine RAVANAT | Received |
P-331 | THAWED PLATELETS AND THAWED PLASMA CAN BE STORED FOR 2 WEEKS AT 4 DEGREES CELSIUS, A POSSIBLE NEW ASSET TO THE TREATMENT OF MAJOR HAEMORRHAGE IN THE PREHOSPITAL SETTING | Femke Noorman | Received |
P-332 | CRYOPRESERVED SHEEP PLATELETS ARE HEMOSTATICALLY FUNCTIONAL: A SUITABLE PRECLINICAL TRANSFUSION MODEL | Gabriela Simonova | Received |
P-345 | HUMAN PLATELETS LABELED AT MULTIPLE BIOTIN DENSITIES: A PROMISING APPROACH FOR MONITORING IN VIVO PLATELET SURVIVAL IN CLINICAL TRIALS | catherine RAVANAT | Received |
P-347 | COLD STORAGES PROVOKES BIOMECHANICAL CHANGES AND AGGREGATE FORMATION IN PLATELET CONCENTRATES | Konstanze Aurich | Received |
P-352 | COMPARISION STUDY OF THE NEWLY LAUNCHED ROCHE ELECSYS INFECTIOUS DISEASE PARAMETERS ON COBAS E 801 IN BLOOD DONOR SCREENING | Caroline Tinguely | Received |
P-354 | HEV RNA SCREENING OF BLOOD DONATIONS BY A COMMERCIAL TRANSCRIPTION-MEDIATED AMPLIFICATION ASSAY (TMA): LINEAR CORRELATION BETWEEN TMA VALUES AND HEV VIRAL LOAD | Sílvia SAULEDA | Received |
P-362 | A SAFE SCREENING ALGORITHM FOR INDIVIDUAL NUCLEIC ACID TESTING (ID-NAT): 10 YEARS OF EXPERIENCE IN A LOW ENDEMIC COUNTRY | Martin Stolz | Received |
P-371 | USE OF A NOVEL TECHNOLOGY TO EFFECTIVELY WASH THE SAMPLE PIPETTOR DURING AUTOMATED BLOOD SCREENING ON THE ALINITY S | Lynn Martin | Received |
P-372 | INDUCTION HEATING: AN ADVANCED WASHING TECHNOLOGY TO PRESERVE SAMPLE INTEGRITY ON ALINITY S FOR TRANSFER TO NAT INSTRUMENTS | Pathik Soni | Received |
P-373 | ABBOTT ALINITY S ASSAYS ROBUSTNESS TO BIOTIN INTERFERENCE | Lynn Martin | Received |
P-375 | PERFORMANCE OF NEW ASSAYS FOR HTLV I/II, HBC AND CHAGAS ON THE FULLY AUTOMATED ABBOTT ALINITY S SYSTEM | Ben Marchlewicz | Received |
P-376 | PERFORMANCE OF NEW ASSAYS FOR HBSAG, HCV, AND HIV AG/AB COMBO ON THE FULLY AUTOMATED ABBOTT ALINITY S SYSTEM | Ben Marchlewicz | Received |
P-404 | HEPATITIS CORE ANTIBODY SCREEING IN BLOOD DONORS IN SAUDI ARABIA | Omer Alsaweed | Received |
P-411 | BLOOD TRANSFUSION SAFETY AND ELIMINATION OF HEPATITIS C IN GEORGIA | Evan Bloch | Received |
aP-440 | IS PARVOVIRUS B19 A CONCERN FOR BLOOD SAFETY IN AUSTRALIA? | Helen Faddy | Received |
P-440 | INACTIVATION OF YELLOW FEVER VIRUS IN PLASMA AND IN PLATELET CONCENTRATES FOLLOWING TREATMENT WITH THE THERAFLEX PATHOGEN INACTIVATION (PI) TECHNOLOGIES | Helen Faddy | Received |
P-473 | EDUCATING RARE DONORS WHY IS THIS IMPORTANT? | Tanya Powley | Received |
P-480 | ABO AND RH PHENOTYPE FREQUENCIES IN DRUZE POPULATION IN NORTHERN ISRAEL | Hanna Morani | Received |
P-485 | AN ANTIBODY AGAINST A NOVEL HIGH INCIDENCE ANTIGEN IN THE INDIAN BLOOD GROUP SYSTEM | Henny Christine | Received |
P-492 | HEMOLYTIC TRANSFUSION REACTION DUE TO AN ANTI-H ANTIBODY IN A SICKLE CELL DISEASE PATIENT | Elena Lazarova | Received |
P-504 | SOFTWARE ASSISTED ANTIBODY IDENTIFICATION - IH-ABID | Paul Aerts | Received |
P-508 | INTRODUCTION OF AUTOMATED HIGH TITRE ANTI-A AND/OR ANTI-B SCREENING IN AUSTRALIAN BLOOD DONORS | Tanya Powley | Received |
P-520 | EXPERIENCE IN THE IMPLEMENTATION OF TYPE AND SCREEN - ABBREVIATED CROSSMATCH PROCEDURE (TAS-CIS) - IN A BLOOD BANK OF A HOSPITALS EMERGENCY CENTER IN LIMA PERU | Elizabeth CARRILLO | Received |
P-525 | NOVEL RECOMBINANT CD38 FOR USE IN PRETRANSFUSION DIAGNOSTICS | Matteo Binda | Received |
P-526 | COMPLICATION IN BLOOD COMPATIBILITY TESTING WITH DARATUMUMAB TREATMENT IN MULTIPLE MYELOMA: A CASE REPORT | ANURAG GUPTA | Received |
P-529 | TWO CASES OF CAUCASIAN BOMBAY AND THREE CASES OF PARA-BOMBAY PHENOTYPE REVEALED FIVE NOVEL FUT1 ALLELES | Hein Hustinx | Received |
P-553 | GENOTYPING PANEL DESIGNED TO IDENTIFY BLOOD DONORS LACKING HIGH PREVALENCE RH ANTIGENS | Margaret Keller | Received |
P-556 | RHD AND RHCE ALLELES IN BRAZILIAN SICKLE CELL DISEASE PATIENTS WITH UNEXPLAINED RH ANTIBODIES | CARLA DINARDO | Received |
P-577 | ASSOCIATION BETWEEN ANTI-D IMMUNOGLOBULIN DEVELOPMENT IN IMMUNISED BLOOD DONORS AND THE RED BLOOD CELL PHENOTYPE | Joanne Tan | Received |
P-583 | RHD TYPING AMBIGUITIES IN MERGING SEROLOGICAL AND MOLECULAR DATA THE DETERMINING CONTRIBUTION OF GENE SEQUENICING | TOMMASO MANCUSO | Received |
P-584 | UTILITY OF RED BLOOD CELL GENOTYPING OF BLOOD DONORS | Margaret Keller | Received |
P-596 | ANTIBODY FORMATION PREDICTION IN TRANSFUSION-DEPENDENT PATIENTS | Joanne Tan | Received |
P-625 | DONOR ANTI-HNA-3A, ANTI-HLA CLASS-I AND ANTI-HLA CLASS-II ANTIBODIES INDUCE NEUTROPHIL- AND MONOCYTE-MEDIATED HLMVEC DAMAGE IN A TWO-INSULT IN VITRO MODEL | John-Paul Tung | Received |
P-663 | CORRELATION BETWEEN CONVENTIONAL COAGULATION TESTS AND ROTEM IN CHILDREN UNDERGOING CRANIOSYNOSTOSIS SURGERY | RANJAN JOSHI | Received |
P-687 | ERYTHROCYTAPHERESIS,USEFUL ADJUNCT THERAPY IN PATIENTS WITH SEVERE MALARIA.HOSPITAL-BASED BLOOD BANK EXPERIENCE | M. Isabel GONZALEZ MEDINA | Received |
P-695 | IRONING OUT ANAEMIA IN PREGNANT WOMEN | Kristy Evans | Received |
P-697 | FERRITIN SCREENING FOR PATIENT BLOOD MANAGEMENT IN PREGNANCY | Philip Crispin | Received |
P-708 | PATIENT BLOOD MANAGEMENT STRATEGIES ASSOCIATED WITH REDUCED TRANSFUSION RATES IN ELECTIVE ORTHOPAEDIC SURGICAL PATIENTS | Leanna Pickles | Received |
P-711 | AGE OF BLOOD DOES NOT IMPACT OF THE FREQUENCY OF BLOOD TRANSFUSION IN MYELODYSPLASTIC SYNDROME | Philip Crispin | Received |
P-719 | FRESH FROZEN PLASMA STORAGE DURATION ASSOCIATED WITH SMALL INCREASED IN-HOPSITAL MORTALITY RISK | John-Paul Tung | Received |
P-758 | ACUTE HAEMOLYTIC TRANSFUSION REACTION DUE TO ANTI-MT | Vincent Claes | Received |
P-770 | HAEMOVIGIL, A NEW SYSTEM TO PREVENT WRONG BLOOD IN TUBE (WBIT) AND TRANSFUSION ERRORS DUE TO PATIENT MIS-IDENTIFICATION: ONE YEAR EXPERIENCE AT A TERTIARY HOSPITAL IN INDIA | Gautam Wankhede | Received |
P-772 | TACO: HOW DO WE PROMOTE AWARENESS AND REPORTING? | Linley Bielby | Received |
P-797 | BLOOD UTILIZATION AND IMPACT OF CHRONIC TRANSFUSION THERAPY (CTT) IN A LARGE COHORT OF BRAZILIAN SICKLE CELL DISEASE (SCD) PATIENTS | shannon kelly | Received |
P-814 | RED BLOOD CELL TRANSFUSION ADEQUACY INDEX AS TOOL FOR IMPROVING PATIENT BLOOD MANAGEMENT PROGRAM. | Gustavo Duarte | Received |
P-829 | THE EFFECT OF CD34-PRE-COUNT, GENDER, AGE AND TYPE OF COLLECTION PROCEDURE ON COLLECTION EFFICIENCY IN STEM CELL COLLECTION FOR MULTIPLE MYELOMA | Francis Swaneveld | Received |
P-832 | THE IMPACT OF THE CRYOPRESERVED PERIOD OF CB UNITS IN THE CHOICE FOR CB TRANSPLANTATION: THE CLINICIANS WOULD PREFER CB UNITS WITH SHORTER CRYOPRESERVED PERIODS THAN LONGER CB UNITS? | Hye Ryun Lee | Received |
P-854 | PERFORMANCE EVALUATION OF THE SPECTRA OPTIA APHERESIS SYSTEM MONONUCLEAR CELL COLLECTION FOR AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION | tamima jisr | Received |
2-6 June 2018 Toronto
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|